Board of Directors

Nandini Piramal is the Chairperson at Piramal Pharma Ltd. She is responsible for setting strategy and driving results at Piramal Pharma. Piramal Pharma offers a portfolio of differentiated products and services through its 17 global development and manufacturing facilities and a global distribution network in over 100 countries.

Additionally, she heads the Human Resources, Finance, Risk, Information Technology and Quality functions at Piramal Pharma.

Ms. Piramal is also an advisor to Piramal Foundation which has impacted the lives of over 113 mm Indians in its lifetime in areas ranging from gender, public health to education and purified water.

She is a visionary business leader driven by her commitment to bettering society. Her efforts in the business and social world led to her being recognized amongst ‘India’s Most Powerful Women’ by Business Today in 2020, 2022, 2023 and 2024 for her outstanding contribution in business and social growth. She has also been recognized by Fortune India in 2025 in the list of their ‘100 Most Powerful Women’. She was also awarded as a `Young Global Leader’ in 2014 by the World Economic Forum.

Ms. Piramal holds a BA (Hons.) in Politics, Philosophy, and Economics from Oxford University. She also has an MBA from Stanford Graduate School of Business. She is also on the board of the Advisory Council of the Stanford Graduate School of Business.

Other Directorships

Peter DeYoung is the CEO of Piramal Global Pharma, Piramal Pharma Limited, and a member of the Piramal Pharma Limited Board. Piramal Global Pharma is comprised of Piramal Pharma Solutions and Piramal Critical Care business units. In his current role, Peter is responsible for steering strategy and driving profitable growth of these businesses.

Prior to this, he has spearheaded several leadership mandates at the Piramal Group, including CEO, Piramal Critical Care and President, Life Sciences.

Previously, Mr. DeYoung worked in various investing and consulting roles in healthcare in the USA, Europe and India. He joined McKinsey & Company in New York after graduating from Princeton, where he worked on a number of projects for pharmaceutical and medical device companies. He was then seconded by McKinsey to the World Economic Forum in Geneva, Switzerland as part of the Global Health Initiative. Mr. DeYoung returned to McKinsey in New York and later in Mumbai, where he focused on the pharmaceutical and healthcare practice. Later, he joined the Blackstone Group’s Private Equity Division in Mumbai where he was part of the deal team for several significant transactions, across a wide spectrum of industry sectors in India.

Mr. DeYoung holds a Master’s Degree in Business Administration from Stanford University (Arjay Miller Scholar), California, USA and a Bachelor’s of Science Degree in Engineering from Princeton University, New Jersey, USA (summa cum laude).

Other Directorships

With over 28 years of overall experience in the field of finance, Mr. Vivek Valsaraj has been associated with the Piramal Group for over 24 years. He currently oversees the Finance, Investor Relations, Company Secretarial and Shared Services Functions of Piramal Pharma Ltd (PPL).

He is an Executive Director on the board of PPL & is serving on the board of the joint venture company of Piramal Pharma Ltd, Abbvie Therapeutics India Private Limited (formerly known as Allergan India Private Limited) and several overseas subsidiaries.

Within the group, he has been associated with various roles in Corporate, the erstwhile Domestic Formulations business and as Financial Controller across the Pharma business. His expertise spans across Corporate Finance, Business Strategy, Mergers and Acquisitions, Corporate Structuring, Corporate Governance & Risks, and Taxation. Over the last several years, he has been closely associated with the Pharma business and has been been a part of several key acquisitions and capital raising. He has also played a key role in streamlining and finessing systems, processes, and internal controls.

Prior to joining Piramal, he was associated with companies like Wockhardt Ltd and Bharat Bijlee Ltd. He holds a Bachelor’s degree is Commerce and is an associate member of the Institute of Cost Accountants of India.

Other Directorships

Mr. Peter Stevenson is a leader in the pharmaceutical industry with extensive manufacturing and commercial experience. He was a member of Pfizer’s Global Manufacturing Leadership Team with responsibilities for global procurement, global external supply and a portfolio of Pfizer internal manufacturing sites in North America, Europe and Asia.

Later, he served as General Manager of Pfizer’s contract manufacturing business and as Value Stream Leader for the Injectables and Hospital Products Value Stream and retired from the role of Vice President, General Manager, Pfizer Centre One in 2019.

Mr. Stevenson also served on the Board of Uniting to Combat Neglected Tropical Diseases.

Earlier in his career, Mr. Stevenson held positions at Rhone Poulenc and Celanese including a 3-year expatriate assignment in France.

He holds a Bachelor’s degree in Arts from Gettysburg College, Pennsylvania.

Other Directorships

Mr. Jairaj Purandare has over four decades of experience in accounting, tax, and business advisory. He is an authority on tax and regulation. He has published papers on subjects like inbound/outbound investment structuring, international tax, transfer pricing, M&As and Indian Budget and Economy. Mr. Purandare has advised clients across various industries such as Financial Services, Infrastructure, Power, Telecom, Media, Pharma and Auto sectors that include Citibank, GE, HSBC, Hutchison, Pepsico, Standard Chartered Bank, News Corp /STAR TV and Tata Group.

Mr. Purandare is the Founder Chairman of JMP Advisors Pvt Ltd, a leading advisory, accounting, tax and regulatory services firm in India. His previous associations has been with firms in various roles such as Regional Managing Partner, Chairman - Tax and Country Leader, Markets & Industries of PricewaterhouseCoopers (PwC) India, Chairman of Ernst & Young India (EY) and Country Head of the Tax & Business Advisory practice of Andersen India.

Mr. Purandare is an Independent Director on the Boards of four large, listed companies. He is a regular speaker at Indian and international seminars and industry forums.

Mr. Purandare is a Fellow of the Institute of Chartered Accountants of India, a steering committee member for the ITSG International Network, and a member of the City of London Advisory Council for India. He is a former member of the National Council of Confederation of Indian Industry (CII) and former Chairman of the Taxation Committee of CII. He has been a member of the Central Direct Taxes Advisory Committee, chaired by the Finance Minister. Mr. Purandare is a YPO Gold member and the former Regional Networks Chair and Finance Chair of YPO.

Mr. Purandare is a Chartered Accountant and holds a Bachelor of Science (Hons) degree from the University of Bombay. Mr. Purandare has completed the YPO Presidents Program from Harvard Business School.

Other Directorships

Ms. Vibha Paul Rishi is a Non-Executive Independent Director, Piramal Pharma Limited.

Ms. Rishi is a marketing professional, specializing in Indian and international markets. She has worked at senior positions globally in branding, strategy, innovation and human capital. She started her career with the Tata Administrative Services and was part of Titan Watches’ founding team. Ms. Rishi had a long association with PepsiCo spanning close to two decades in marketing and innovation roles for India, USA and the UK. She was also the Executive Director (Brand and Human Capital) at Max India Ltd. and the Director (Marketing and Customer Strategy) at the Future Group with stints across the globe, coupled with an abiding passion for people.

Ms. Rishi currently serves on the board of reputed companies such as ICICI Bank Limited and ICICI Prudential Life Insurance Company Limited. She is also on the Board of Pratham, an NGO that works to provide education to underprivileged children in India.

Ms. Rishi holds a BA Degree in Economics from Lady Sri Ram College, University of Delhi and an MBA with specialization in marketing from the Faculty of Management Studies, New Delhi.

Other Directorships

Mr. Sridhar Gorthi is a founding partner and member of the Management Committee at Trilegal. He is an authority in corporate law, M&A, and private equity, spanning across sectors including manufacturing, pharmaceuticals, insurance, banking and financial services, technology, telecom and media.

His domain knowledge has earned him the recognition of Asian Law Firm Leader of the Year - Asia Legal Awards 2023, 'Leading Individual' - Corporate M&A, Legal 500 Asia Pacific for 2024 and a distinguished practitioner for Corporate M&A and private Equity by the Asia Law Profiles (2023). His name also lists as a 'Highly Regarded’ lawyer – M&A by IFLR1000 (2019-2023). He is among India Business Law Journal’s A-list 2023 of top 100 lawyers in India, and among Chambers and Partners’ Asia Pacific’s leading lawyers in India for Banking and Finance (2014-2024).

Mr. Gorthi is a graduate from National Law School, Bengaluru, and is a member of the Bar Council of Maharashtra and Goa.

Other Directorships

Ms. Nathalie Leitch has over 20 years of experience in the pharmaceuticals industry across multiple segments. She has led commercial management of a branded product line and oversaw the largest pipeline of generic products in the industry. A subject-matter expert in the US generics industry, Ms. Leitch has domain experience in creative product strategies and 505(b)(2) formulations; patent challenges, Hatch-Waxman and settlement options; business development and external-partnering activities. Additionally, she has extensive knowledge of sales, marketing, R&D and manufacturing functions.

Ms. Leitch has steered organizational success in the generic retail and institutional markets. She held senior leadership positions at Apotex, Fresenius Kabi, Teva Pharmaceuticals, Allergan plc, and Actavis (formerly Watson). She has been instrumental in driving company acquisitions and overall consolidation.

Ms. Leitch has a B.Sc. in Human Biology from Trinity College, University of Toronto, Canada, and holds a Finance MBA from Queen’s University, Kingston, Canada.

Amit Jain is a Managing Director, Partner and Head of Carlyle India Advisors. Prior to Carlyle, Mr. Jain served for ten years at Blackstone in India, most recently as Senior Managing Director in its Private Equity Group where he focused on investments in the consumer, healthcare, auto, telecom and packaging sectors as well as parts of financial services. He held board positions in numerous companies including EPL, Aakash Educational Services, Aakash Edutech, Comstar Automotive Technologies, SONA BLW Precision Forgings, FINO Payments Bank, FINO Finance, FINO Paytech and CMS Infosystems. Currently he is on the Board of Varmora Granito, VLCC & Viyash Lifesciences. Prior to Blackstone, Amit was a consultant at McKinsey & Company and started his career with Unilever in operating roles.

He holds an MBA from the Indian School of Business, Hyderabad, where he was conferred 'ISB Scholar of Excellence and B.Tech in Mechanical Engineering from the Indian Institute of Technology (IIT), Kharagpur, where he was awarded the 'Institute Silver medal' for his academic performance.

Amit was recognized by the Economic Times as one of the India's '40 Under Fourty' young business leaders 2019. He was also awarded the Young business leaders in 2019. He was also awarded the Young Alumni Achieve Award (YAAA) by his alma mater, IIT Kharagpur.

Other Directorships

Amit is a Partner at CVC Capital and started its India business in 2017. Under his leadership, the India office has deployed $980 million across 5 deals. Some of its notable investments are the creation of Gujarat Titans, a team in the successful cricket franchise, the Indian Premier League and a majority stake in Healthcare Global, a leading oncology chain in India. Amit has over two decades of experience in partnering with founders, management teams, business families and the Government in helping create and scale businesses that have the potential for significant impact.

Prior to CVC, Amit spent 9 years with General Atlantic and led their investments in technology, financial services and healthcare space in India. Some of his key investments were (i) Bill Desk: leading digital payments solution provider in India (ii) CitiusTech: a global healthcare technology company focused on improving experience and outcomes (iii) IndusInd Bank: 4th largest private bank in India with deep focus on SME customers; (iv) MedExpress: urgent care business model that helps payers address emergency care visits in a customer centric manner; (v) Red Ventures, owner of niche media assets with strong analytics to sell subscription products to consumers.

Amit has also worked at 3i, Bill & Melinda Gates Foundation and McKinsey & Company. He holds an MBA from The Wharton School and a Bachelor of Technology degree in Electrical Engineering from IIT Delhi.

Other Directorships